Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:31:58 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:FOLD - AMICUS THERAPEUTICS INC - https://www.amicustherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FOLD - Q44.814.28·14.400.114.30+0.020.124,424.8347,86112,69314.30  14.30  14.2614.38  5.5117:10:11Feb 0315 min RT 2¢

Recent Trades - Last 10 of 12693
Time ETExPriceChangeVolume
17:10:11Q14.28050.000537
16:35:01Q14.300.0210
16:10:04Q14.300.021
16:10:04Q14.300.021
16:04:54Q14.300.021
16:04:52Q14.300.021
16:04:35Q14.300.021
16:04:16Q14.300.021
16:04:16Q14.300.021
16:04:07Q14.300.021

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-03 08:00U:FOLDNews ReleaseAmicus Therapeutics Presents New Long-term Data for both Galafold(TM) (migalastat) and POMBILITI(TM) (cipaglucosidase alfa-atga) + OPFOLDA(TM) (miglustat) at the 22nd Annual WORLDSymposium(TM) 2026
2025-12-19 07:45U:FOLDNews ReleaseBioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
2025-11-04 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates
2025-10-31 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
2025-10-23 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025
2025-09-08 09:00U:FOLDNews ReleaseNew 4-Year Data for Pombiliti(TM) (cipaglucosidase alfa-atga) + Opfolda(TM) (miglustat) Presented at ICIEM
2025-08-29 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
2025-07-31 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
2025-07-21 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
2025-06-25 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Approval of Pombiliti(TM) (cipaglucosidase alfa) + Opfolda(TM) (miglustat) in Japan
2025-06-03 07:00U:FOLDNews ReleaseNew Analysis of Pombiliti(TM) (cipaglucosidase alfa-atga) + Opfolda(TM) (miglustat) Published in Muscle and Nerve
2025-05-30 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in June 2025
2025-05-07 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
2025-05-01 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
2025-04-30 19:13U:FOLDNews ReleaseDimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
2025-04-21 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
2025-02-27 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
2025-02-19 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
2025-02-10 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025